数百万元现金用编织袋装入医院院长后备箱！官方披露一商业贿赂案

Core Viewpoint - The case involving Chongqing Kangrong Medical Equipment Co., Ltd. highlights significant issues of commercial bribery in the medical sector, with the company’s actual controller, Wang, allegedly paying a total of 8 million yuan in bribes to a hospital director to secure business advantages [1][3]. Group 1: Case Details - The bribery case amounts to 8 million yuan, with multiple instances of cash payments made by Wang to the hospital director, Sun, over several years [1][2]. - Wang provided bribes in various forms, including cash in bags, with the largest single payment being 2 million yuan in 2018 [2]. - The payments were made under the pretext of seeking assistance for medical equipment procurement and other business opportunities [2]. Group 2: Implications for the Industry - The practice of medical commercial bribery undermines fair competition and increases the cost of medical products, as the bribes are ultimately included in the product costs, leading to inflated prices [3]. - The actions of the hospital director, who accepted bribes, compromised the integrity of the procurement process and disadvantaged compliant businesses [3]. - As a result of the findings, Chongqing Kangrong Medical Equipment Co., Ltd. has been classified as "particularly seriously untrustworthy" and has had its distribution qualifications suspended for five years in the Chongqing medical procurement market [3].